News
UK health data ecosystem 'is hampering research'

UK health data ecosystem 'is hampering research'

The UK is squandering the vast resource of NHS patient data because too many obstacles are being placed in front of researchers trying to tap into it – holding back medical advances.

News
Healint's Migraine Buddy app

Aptar buys digital health partner Healint

More evidence of consolidation in the digital health category has come with the news that Aptar has bought Singapore’s Healint, which develops patient support apps as well

R&D
JP Morgan 2024 – Sam Deutsch

JP Morgan 2024 – Sam Deutsch

In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica

Debates & Insights

News

News
UK health data ecosystem 'is hampering research'

UK health data ecosystem 'is hampering research'

The UK is squandering the vast resource of NHS patient data because too many obstacles are being placed in front of researchers trying to tap into it – holding back medical advances.

Press Releases

Editor's Picks

  1. Novo Nordisk will file semaglutide for MASH next year
  2. Eledon drug helps transplants 'cure' type 1 diabetes
  3. UK Chancellor pledges £22bn rise in day-to-day NHS spending
  4. Teva fined €462.6m for antitrust delay to MS drug rivals
  5. Novartis pays $150m upfront for Monte Rosa degrader drug

Newsletters and Deep Dive
digital magazine

Views & Analysis

more

Deep Dive

R&D
Heard on the pipeline hexagon graphical banner

Heard on the pipeline: AI in R&D

As has become tradition in the pharma and biotech world, 2024 kicked off with a bang as experts from around the globe gathered in San Francisco for the 42nd annual JP Morgan Health Conferen

more

Webinars

more

Podcasts

R&D
LSX USA Jonah Comstock and Eloise McLennan Wrapup

Investment outlook: Key takeaways from LSX USA

Investment and strategic partnerships are the lifeblood of innovation in healthcare, driving groundbreaking discoveries and accelerating the development of life-changing therapies.

R&D
Frantz Maignan and Grant Brock podcast
Sponsored

Tips for on-time tech transfers that stay on budget

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, pr

more

Video

R&D
Jonah Comstock interview with Dr Tadaaki Taniguchi

LSX 2024 - Dr Tadaaki Taniguchi

At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r

more

White Papers

R&D
Envisioning a World Without Disease - whitepaper

Envisioning a World Without Disease

In June, pharmaphorum came together with the Connected World Without Disease Accelerator for the inaugural World Without Disease Summit, a two-day event that brought together stakeholders f

more

Event

R&D
FT US Pharma and Biotech Summit

FT US Pharma and Biotech Summit: Live coverage

This week, pharmaphorum heads to the Big Apple for the FT US Pharma and Biotech Summit, a one-day event where executives from some of the world’s top pharma companies will come together to

R&D
FT LiveUS Pharma and Biotech Summit 2023

FT Live US Pharma and Biotech Summit 2023

At the FT’s US Pharma and Biotech Summit in New York City, 16th and 17th May, leaders from across the pharma landscape will gather to discuss some of the hottest topics in US pharma, includ

more

Partner Content

R&D
EHS&S for Biopharma & Pharma Summit banner
Partner Content

EHS&S for Biopharma & Pharma Summit

Implementing Corporate & Regulatory-Guided EHS Practices to Achieve Zero Biosafety, Ergonomic & Chemical Incidents for Employee Safety Across Global Facilities

more